mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
1 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.001 |
1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |